• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    US Healthcare Ishares ETF (NY: IYH )

    62.34 -0.34 (-0.55%)
    Streaming Delayed Price Updated: 3:49 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about US Healthcare Ishares ETF

    < Previous 1 2 Next >
    What Lies In Store For Healthcare ETFs In Q3 Earnings?
    The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited. 
    Via Talk Markets
    Topics ETFs
    Deere, Amgen, Copart And More: CNBC's 'Final Trades'
    On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Deere & Company as his final trade. 
    Via Benzinga
    Defensive ETFs Shine Amid A Rough Start To September
    U.S. stocks started September on a dismal note on economic slowdown concerns following weak data, which shows that manufacturing shrank again in August. 
    Via Talk Markets
    Topics ETFs
    AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
    Via Benzinga
    Delta Air Lines, Interactive Brokers And More: CNBC's 'Final Trades'
    Delta shares fell 3.5% to close at $43.83 on Monday. It struggles to recover from the cyber outage that impacted operations last week. 
    Via Benzinga
    Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
    Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks among health insurers. 
    Via Benzinga
    Topics Government
    Exposures Political
    Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
    You don't need to be a stock market expert to earn above-average returns. 
    Via The Motley Fool
    'Barbarism:' AOC Unleashes Fury On US Healthcare System As People Are 'Choosing Between Medicine And Rent'
    America has one of the highest healthcare costs in the world, with healthcare spending hitting $4.5 trillion in 2022. 
    Via Benzinga
    ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
    Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest... 
    Via Talk Markets
    Topics ETFs
    Target, Apollo Global Management, Las Vegas Sands And More: CNBC's 'Final Trades'
    On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors named Apollo Global Management, Inc. 
    Via Benzinga
    Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
    According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.  
    Via Benzinga
    Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
    On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc (NYSE: SHAK) 
    Via Benzinga
    Cigna Drops Humana Merger, Opts For $10 Billion Buyback Strategy
    In a recent development in the health insurance sector, Cigna Corporation (NYSE: CI) has withdrawn from its proposed merger with Humana Inc. (NYSE: 
    Via Benzinga
    Humana, Comerica, Cleveland-Cliffs, And More: CNBC's 'Final Trades'
    On CNBC’s "Halftime Report Final Trades," Shannon Saccocia of Boston Private named iShares U.S. 
    Via Benzinga
    Cisco, Burlington Stores, Broadcom And More On CNBC's 'Final Trades'
    It has been "a really tough year" for the healthcare sector. That's according to Shannon Saccocia of Boston Private, who appeared on CNBC’s "Halftime Report Final Trades." 
    Via Benzinga
    Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups
    A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests to detect diseases sooner and personalize treatments. 
    Via Benzinga
    Exposures Product Safety
    All eyes on the Fed as inflation metrics give mixed signals
    Although the FOMC will almost certainly keep the Fed funds rate steady this week, investors aren’t yet convinced that the rate hike cycle has ended. 
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Beyond The Hustle: Embracing Ancient Chinese Wisdom To Combat Modern Day Burnout
    In our modern, high-speed society, many find themselves exhausted in the relentless chase for achievement. Yet, a concept from ancient China that dates back 2,000 years might offer a path to... 
    Via Benzinga
    4 Top-Ranked Sector ETFs To Buy In The Second Half
    Investors could be well served by ETFs from sectors that house the top-ranked industries. 
    Via Talk Markets
    From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
    Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... 
    Via Benzinga
    The 3 Most Promising Industries to Invest in for 2023’s Second Half
    Discover the most promising industries to invest in. Unlock the top sectors for investing and seize lucrative opportunities. 
    Via InvestorPlace
    Stocks Flounder Despite Inflation Downtrend As Banking Crisis Emerges, But Outlook Remains Encouraging
    Nothing goes in a straight line for long, and inflation is no different, i.e., the path is volatile, but disinflationary trends remain intact. 
    Via Talk Markets
    Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul
    These exchange-traded funds have soundly beaten the S&P 500 over the past 10 years. 
    Via The Motley Fool
    Uncertainties On Fed Policy, Geopolitics, And Earnings Cloud 2023 Outlook, But Trends Are Promising
    The future direction of both stocks and bonds hinges on the trajectory of corporate earnings and interest rates, both of which are largely at the mercy of inflation, Fed monetary policy, and the state... 
    Via Talk Markets
    Worried About 2023? Here's a Safer Way to Invest in Stocks This Year
    By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk. 
    Via The Motley Fool
    The 3 Best Sectors to Invest in for 2023
    A blend of value and growth defines the best sectors to invest in for 2023. These three sectors best fit the definition. 
    Via InvestorPlace
    Health Care Exposure Ahead Of CPI Data, Progressive, Dollar General And Seagate Technology Feature On CNBC's 'Final Trades'
    On CNBC’s “Halftime Report Final Trades,” Courtney Garcia of Payne Capital Management said that health care is going to be among the outperformers. 
    Via Benzinga
    Investors Await Bullish Catalysts As Inflation, Interest Rates, And Money Supply Growth Show Signs Of Topping
    Although the Fed likely will raise rates another 50-75 bps in July, it will not raise as much as the market is pricing in, and indeed the Fed may instead be forced to ease later this year or early next... 
    Via Talk Markets
    CNBC's Final Trades: Microsoft, US Dollar Index, iShares Healthcare ETF And This Cybersecurity Tech Major
    On CNBC’s “Halftime Report Final Trades 
    Via Benzinga
    Adobe Earnings Strangle Trade
    Adobe announces earnings this week, and we plan on using an options strategy called a 
    Via Talk Markets
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.